Balyasny Asset Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.21M | Buy |
+1,338,214
| New | +$9.21M | 0.01% | 713 |
|
|
2024
Q4 | – | Sell |
-10,374
| Closed | -$37K | – | 2075 |
|
|
2024
Q3 | $37K | Sell |
10,374
-993
| -9% | -$3.55K | ﹤0.01% | 1874 |
|
|
2024
Q2 | $70.5K | Sell |
11,367
-4,342
| -28% | -$26.9K | ﹤0.01% | 1788 |
|
|
2024
Q1 | $148K | Sell |
15,709
-89,470
| -85% | -$845K | ﹤0.01% | 1839 |
|
|
2023
Q4 | $710K | Buy |
+105,179
| New | +$710K | ﹤0.01% | 1311 |
|
|
2023
Q3 | – | Sell |
-11,087
| Closed | -$36.6K | – | 1910 |
|
|
2023
Q2 | $36.6K | Buy |
+11,087
| New | +$36.6K | ﹤0.01% | 1743 |
|
|
2022
Q3 | – | Sell |
-15,684
| Closed | -$77K | – | 2478 |
|
|
2022
Q2 | $77K | Buy |
+15,684
| New | +$77K | ﹤0.01% | 1863 |
|
|
2022
Q1 | – | Sell |
-11,734
| Closed | -$208K | – | 2242 |
|
|
2021
Q4 | $208K | Buy |
+11,734
| New | +$208K | ﹤0.01% | 1608 |
|